Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gastrointestinal 1Dermatologic 1

Conditions

Pancreatic Neoplasms 26Urinary Bladder Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 13Ovarian Neoplasms 10Nasopharyngeal Carcinoma 9Biliary Tract Neoplasms 8Non-Muscle Invasive Bladder Neoplasms 7Neoplasm Metastasis 7Cholangiocarcinoma 7Lymphoma, Large B-Cell, Diffuse 6Triple Negative Breast Neoplasms 5Colorectal Neoplasms 5Breast Neoplasms 5Recurrence 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasms 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Carcinoma, Transitional Cell 4Osteosarcoma 3Melanoma 3Lymphoma, Non-Hodgkin 3Uterine Cervical Neoplasms 2Urologic Neoplasms 2Rectal Neoplasms 2Lymphoma, Follicular 2Lymphoma, B-Cell 2Gallbladder Neoplasms 2Colonic Neoplasms 2

Interventions

pembrolizumab 32Cisplatin 23Cetuximab 14Carboplatin 13Magnetic Resonance Spectroscopy 12Specimen Handling 10Radiotherapy, Intensity-Modulated 10Paclitaxel 9Nivolumab 9Docetaxel 8Platinum 71,2-diaminocyclohexaneplatinum II citrate 7Radiotherapy 5Biopsy 5dostarlimab 4atezolizumab 4Immunoglobulin G 4Disulfides 4Bevacizumab 4(225)Ac-DOTA-c(RGDyK) 4cemiplimab 3Taxes 3Radiation 3Fulvestrant 3Fluorouracil 3budigalimab 2amivantamab 2abemaciclib 2Radiotherapy, Image-Guided 2Pemetrexed 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × Gemcitabine × 30 days × Clear all
NCT04083599 2026-06-02

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Genmab

Phase 1/2 Active not recruiting
350 enrolled
DermatologicGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡